Capital Fund Management (CFM)’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-20,600
Closed -$118K 767
2018
Q4
$118K Buy
+20,600
New +$118K ﹤0.01% 781